Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
D001792:Blood Platelets / Q000032:analysis / Q000378:metabolism*; D002994:Clofibrate / Q000627:therapeutic use; D003094:Collagen / Q000494:pharmacology; D004176:Dipyridamole / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010545:Peroxides / Q000097:blood; D011446:Prospective Studies; D011453:Prostaglandins / Q000096:biosynthesis / Q000097:blood; D011460:Prostaglandins F / Q000032:analysis; D011725:Pyridines / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000209:etiology; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology*
D010545:Peroxides; D011453:Prostaglandins; D011460:Prostaglandins F; D011725:Pyridines; D013876:Thiophenes; D004176:Dipyridamole; D006493:Heparin; D003094:Collagen; D002994:Clofibrate; D013442:Sulfinpyrazone